NFKB1 and Alzheimer disease: The NF-κB signaling pathway, a core neuroinflammatory pathway, and its related molecules has been found to be associated with AD in multiple brain regions, including the frontal cortex BA9, putamen basal ganglia, nucleus accumbens basal ganglia, substantia nigra, and cervical spinal cord c-1.